12.04.2010Biocartis raises €30 million in Series B' financing round

Press Release
30.03.2010The Leukemia & Lymphoma Society and Avila Therapeutics Enter Partnership to Accelerate Development of AVL-292 For Patients with Cell B Malignancies

Press Release
22.03.2010Impressive report issued by Soleil Securities on Advent portfolio company Cellnovo

In The News
16.03.20104-Antibody announces long-term collaboration with Boehringer Ingelheim with a maximum value of EUR 177.5m (CHF 266m) for 4-Antibody

Press Release
10.02.2010Biocartis acquires Philips Technology Platform for Automated DNA/RNA Molecular Diagnostic Testing

Press Release
19.01.2010AMT submits its lead product Glybera® Application for Marketing Authorisation Application to EMA

Press Release
24.11.2009Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds

Press Release
03.11.2009Avila presents data on its novel, orally-available protease inhibitor, AVL-181, demonstrating viral clearance of hepatitis C virus in preclinical models

Press Release
02.11.2009Micromet and Sanofi-aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody

Press Release
20.10.2009Privately held CardiacAssist reports record revenues for nine-month financial results

Press Release